CAS: 264233-05-8
CID 2745687
CAS:264233-05-8
Formula:
C17H19F2N5O2S
Purity:
≥95%
Color and Shape:
Solid
Molecular weight:
395.4269
Ref: AN-AG00C2VK
5mg | 242.00 € | |
25mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
CID 2745687
CAS:264233-05-8
CID 2745687 is a GPR35 antagonist that inhibited the effects at human GPR35 of cromolyn …
Formula:
C17H19F2N5O2S
Purity:
99.11%
Color and Shape:
Solid
Molecular weight:
395.43
Ref: TM-T21874
1mg | 40.00 € | |
2mg | 52.00 € | |
5mg | 87.00 € | |
10mg | 123.00 € | |
25mg | 269.00 € | |
50mg | 423.00 € | |
100mg | 628.00 € | |
1ml*10 (DMSO) | 96.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
Methyl 1-(2,4-Difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate
CAS:264233-05-8
Applications Used as a GPR35 antagonist, with potential application towards immune or gastrointestinal system regulation. …
Formula:
C17H19F2N5O2S
Molecular weight:
395.427
Ref: TR-M301800
250mg | 3,618.00 € |
Estimated delivery in United States, on Monday 1 Jul 2024
Methyl 1-(2,4-Difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate
CAS:264233-05-8
Methyl 1-(2,4-difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate (SNX-111) is a drug that has been shown to be useful in the …
Formula:
C17H19F2N5O2S
Purity:
Min. 95%
Molecular weight:
395.43 g/mol
Ref: 3D-FM102381
100mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024